Effectiveness of Adding Metacognitive Training to Occupational Therapy in Patients With Schizophrenia Under Long-Term Hospitalization: A Pilot Randomized Controlled Trial
- PMID: 40851683
- PMCID: PMC12368383
- DOI: 10.7759/cureus.88476
Effectiveness of Adding Metacognitive Training to Occupational Therapy in Patients With Schizophrenia Under Long-Term Hospitalization: A Pilot Randomized Controlled Trial
Abstract
Objective This study investigated the effects of metacognitive training (MCT) on improving psychiatric symptoms and cognitive function in patients with schizophrenia who were hospitalized for long periods. Methods The participants were long-term inpatients with schizophrenia, hospitalized in a private psychiatric hospital in Japan. Participants were randomly assigned to either the occupational therapy (OT)+MCT group or the OT-alone group. The OT+MCT group received 16 weekly MCT sessions, each lasting 60 minutes, over a period of four months. The Japanese versions of the Montreal Cognitive Assessment (MoCA-J), Positive and Negative Syndrome Scale (PANSS), Beck Cognitive Insight Scale (BCIS), and Global Assessment of Functioning (GAF) scores were compared before and after the intervention using a two-way repeated measures analysis of variance. To examine age-related effects, a correlation analysis was performed between participants' age and their MoCA-J total score. Furthermore, the OT+MCT group was stratified by median age (68 years), and changes in each outcome measure were compared between the groups. Results The 41 participants had a mean age of 69.22 years, ranging from 37 to 79 years, with 21 assigned to the OT+MCT group and 20 to the OT-alone group. There were no dropouts during the study period. The mean MoCA-J Total score at baseline was 17.67 (SD = 5.37) in the OT+MCT group and 14.85 (SD = 5.95) in the OT-alone group, indicating mild cognitive impairment in both groups. Four months after the intervention, both groups demonstrated an upward trend in MoCA-J scores. Notable improvements were seen in visuospatial/executive and total scores over time in both groups. However, no significant between-subject effects or interaction effects were detected. Additionally, a significant negative correlation was observed between age and the MoCA-J total score. In the PANSS, scores decreased in both groups at the post-intervention assessment, and significant differences were observed in general psychopathology and total score categories due to within-subjects factors. Negative symptom scores significantly differed between groups; however, no interaction with time was observed. Participants aged 68 or older showed greater reductions in PANSS scores. While no significant differences were observed in positive symptoms, significant improvements were observed in negative symptoms, general psychopathology, and overall PANSS scores. No significant differences were observed between the two groups in either the BCIS or GAF scores. Conclusions These findings suggest that MCT is feasible for long-term hospitalized elderly patients with schizophrenia and may improve psychiatric symptoms when combined with OT. Although OT+MCT did not significantly improve cognitive function, the results suggest it may be particularly beneficial for older patients in managing persistent psychiatric symptoms. Future studies should investigate the cognitive effects of MCT in larger samples, determine optimal treatment duration and frequency, and explore potential interactions with medications.
Keywords: beck cognitive insight scale; elderly; global assessment of functioning; long-term hospitalization; metacognitive training; montreal cognitive assessment (moca); occupational therapy; panss; randomized controlled trial; schizophrenia.
Copyright © 2025, Sunohara et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Ethics Committee of the Faculty of Medicine, Shinshu University issued approval 5181. The study was also approved by the Ethics Committee of the Uetmatsu Hospital. It was registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) (registration number: UMIN000044956). Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures



Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD013100. doi: 10.1002/14651858.CD013100.pub2. Cochrane Database Syst Rev. 2022. PMID: 35844143 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
-
- OECD Reviews of Public Health: Japan: A Healthier Tomorrow. Paris, France: OECD Publishing; 2019.
-
- Ministry of Health, Labour and Welfare: Building a community-based integrated care system that also addresses mental disorders [Webpage in Japanese] [ Mar; 2024 ]. 2020. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/chiikihoukatsu.html https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/chiikihoukatsu.html
-
- The Current State of Mental Health, Medical Care, and Welfare of Long-Term Hospitalized Patients with Mental Disorders [Document in Japanese] Tokyo, Japan: Ministry of Health, Labour and Welfare; [ Mar; 2024 ]. 2014. The Current Situation Surrounding Long-Term Hospitalized Patients with Mental Disorders.
-
- Online survey of physicians on the causes of long-term hospitalization of schizophrenia patients [Article in Japanese] Taneda Y, Nagura H, Takano A. https://jglobal.jst.go.jp/en/detail?JGLOBAL_ID=202302234457969810 Shinryō to Shin'yaku. 2023;60:285–295.
-
- Long-term care utilization within older adults with schizophrenia: associated factors in a multicenter study. Lavaud P, McMahon K, Sánchez Rico M, et al. Psychiatry Res. 2022;308:114339. - PubMed
LinkOut - more resources
Full Text Sources